Gaudium IVF and Women Health Limited was originally incorporated in the name of "Gaudium IVF and Women Health Private Limited" as a Private Limited Company, dated March 24, 2015 with the RoC, Delhi and Haryana. Subsequently, the status of the Company was converted from a Private Limited into a Public Limited and the name was changed to `Gaudium IVF and Women Health Limited`, and a fresh Certificate of Incorporation dated October 24, 2024 was issued by the Central Processing Center.
Company is engaged in IVF (In vitro fertilization) treatment in India and has grown into several states with Hub and spoke model over the years. Gaudium IVF is founded by the Promoter Dr. Manika Khanna, a specialist with advanced training in gynecological endoscopic surgery from Kiel, Germany, and in Gynaec Endoscopy from Melbourne IVF Gujarat Private Limited. The Company operates 30 locations, which comprises of 7 hubs (centers) and 28 spokes (company has entered into a strategic alliance with Spokes i.e Infertility Expert to achieve the mutual goal of spreading awareness about ART and IVF treatment). Their treatments include In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI) and ovulation induction, all our treatment is carefully designed to address a variety of infertility challenges for both male and female.
The Company began its journey by starting the business operations at Gaudium Hospital in 2019. Gaudium IVF and Gynae Solutions, a proprietary firm of Dr. Manika Khanna, was acquired by the Company in accordance with the main object clause, pursuant to a preferential allotment dated March 29, 2021. This acquisition was executed through the issuance of 9,40,232 equity shares.
The Company acquired 100% shares of Gaudium International Private Limited, making it a wholly owned subsidiary of the Company on February 2, 2023. The Company further acquired Gaudium Bawa Ludhiana Centre as a going concern via slump sale in 2023.
In 2024, Company has started Srinagar Centre in Jammu & Kashmir; started Banglore Centre in Karnataka.
The Company offer a complete specialized fertility and reproductive health services. The advance treatments include In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), and ovulation induction, all our treatment is carefully designed to address a variety of infertility challenges for both male and female. It also offers comprehensive gynecological care, including PCOD/PCOS and endometriosis. Further, high-risk pregnancy management is provided for women with complex fertility histories or health conditions. The wellness aspect includes fertility wellness programs, offering nutritional counselling and psychological support to ensure holistic care for couples undergoing treatments.
Apart from these, the facilities provide a comprehensive range of male infertility treatments, including advanced sperm retrieval techniques. For fertility preservation, Company offer cryopreservation services for eggs freezing for future fertilization, utilizing state-of-the-art technology to ensure optimal success rates in future IVF cycles. Additionally, the centers specialize in Frozen Embryo Transfers (FET). They also offer laparoscopic and hysteroscopic surgeries for diagnosis and treatment of infertility-related conditions, as well as genetic testing options, including Preimplantation Genetic Testing (PGT), designed to enhance pregnancy outcomes and mitigate the risks of genetic disorders.
The Company is planning an Initial Public Issue aggregating of upto 2,08,86,100 Equity Shares of face value of Rs 5/- each comprising a fresh issue of 1,83,54,400 equity shares and 25,31,700 equity shares through offer for sale.
Gaudium IVF and Women Health share price as on 02 Mar 2026 is Rs. 82.72. Over the past 6 months, the Gaudium IVF and Women Health share price has increased by 0% and in the last one year, it has increased by 0%. The 52-week low for Gaudium IVF and Women Health share price was Rs. 76.25 and 52-week high was Rs. 87.15.
Gaudium IVF and Women Health Limited was originally incorporated in the name of "Gaudium IVF and Women Health Private Limited" as a Private Limited Company, dated March 24, 2015 with the RoC, Delhi and Haryana. Subsequently, the status of the Company was converted from a Private Limited into a Public Limited and the name was changed to `Gaudium IVF and Women Health Limited`, and a fresh Certificate of Incorporation dated October 24, 2024 was issued by the Central Processing Center.
Company is engaged in IVF (In vitro fertilization) treatment in India and has grown into several states with Hub and spoke model over the years. Gaudium IVF is founded by the Promoter Dr. Manika Khanna, a specialist with advanced training in gynecological endoscopic surgery from Kiel, Germany, and in Gynaec Endoscopy from Melbourne IVF Gujarat Private Limited. The Company operates 30 locations, which comprises of 7 hubs (centers) and 28 spokes (company has entered into a strategic alliance with Spokes i.e Infertility Expert to achieve the mutual goal of spreading awareness about ART and IVF treatment). Their treatments include In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI) and ovulation induction, all our treatment is carefully designed to address a variety of infertility challenges for both male and female.
The Company began its journey by starting the business operations at Gaudium Hospital in 2019. Gaudium IVF and Gynae Solutions, a proprietary firm of Dr. Manika Khanna, was acquired by the Company in accordance with the main object clause, pursuant to a preferential allotment dated March 29, 2021. This acquisition was executed through the issuance of 9,40,232 equity shares.
The Company acquired 100% shares of Gaudium International Private Limited, making it a wholly owned subsidiary of the Company on February 2, 2023. The Company further acquired Gaudium Bawa Ludhiana Centre as a going concern via slump sale in 2023.
In 2024, Company has started Srinagar Centre in Jammu & Kashmir; started Banglore Centre in Karnataka.
The Company offer a complete specialized fertility and reproductive health services. The advance treatments include In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), and ovulation induction, all our treatment is carefully designed to address a variety of infertility challenges for both male and female. It also offers comprehensive gynecological care, including PCOD/PCOS and endometriosis. Further, high-risk pregnancy management is provided for women with complex fertility histories or health conditions. The wellness aspect includes fertility wellness programs, offering nutritional counselling and psychological support to ensure holistic care for couples undergoing treatments.
Apart from these, the facilities provide a comprehensive range of male infertility treatments, including advanced sperm retrieval techniques. For fertility preservation, Company offer cryopreservation services for eggs freezing for future fertilization, utilizing state-of-the-art technology to ensure optimal success rates in future IVF cycles. Additionally, the centers specialize in Frozen Embryo Transfers (FET). They also offer laparoscopic and hysteroscopic surgeries for diagnosis and treatment of infertility-related conditions, as well as genetic testing options, including Preimplantation Genetic Testing (PGT), designed to enhance pregnancy outcomes and mitigate the risks of genetic disorders.
The Company is planning an Initial Public Issue aggregating of upto 2,08,86,100 Equity Shares of face value of Rs 5/- each comprising a fresh issue of 1,83,54,400 equity shares and 25,31,700 equity shares through offer for sale.
Gaudium IVF and Women Health share price as on 02 Mar 2026 is Rs. 82.72. Over the past 6 months, the Gaudium IVF and Women Health share price has increased by 0% and in the last one year, it has increased by 0%. The 52-week low for Gaudium IVF and Women Health share price was Rs. 76.25 and 52-week high was Rs. 87.15.
